Scribd Logo
Upload

Welcome to Scribd!

  • 1K views

    Mefenamic Acid

    Uploaded by

    Angelica Cassandra Villena
    This document is a drug study for a 42-year-old male patient named JB who was admitted on August 6, 2014 for post cholelithiasis and prescribed the drug Mefenamic Acid. Mefenamic Acid is a nonsteroidal anti-inflammatory drug (NSAID) to be taken three times daily for pain, fever, and inflammation. Potential side effects include gastrointestinal issues, headaches, and renal problems. Nursing responsibilities include administering the medication correctly and monitoring the patient for effectiveness, side effects, and lab abnormalities.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd

    Mefenamic Acid

    Uploaded by

    Angelica Cassandra Villena
    1K views3 pages
    This document is a drug study for a 42-year-old male patient named JB who was admitted on August 6, 2014 for post cholelithiasis and prescribed the drug Mefenamic Acid. Mefenamic Acid is a nonsteroidal anti-inflammatory drug (NSAID) to be taken three times daily for pain, fever, and inflammation. Potential side effects include gastrointestinal issues, headaches, and renal problems. Nursing responsibilities include administering the medication correctly and monitoring the patient for effectiveness, side effects, and lab abnormalities.

    Original Description:

    sample ds

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document is a drug study for a 42-year-old male patient named JB who was admitted on August 6, 2014 for post cholelithiasis and prescribed the drug Mefenamic Acid. Mefenamic Acid is a nonsteroidal anti-inflammatory drug (NSAID) to be taken three times daily for pain, fever, and inflammation. Potential side effects include gastrointestinal issues, headaches, and renal problems. Nursing responsibilities include administering the medication correctly and monitoring the patient for effectiveness, side effects, and lab abnormalities.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    1K views3 pages

    Mefenamic Acid

    Uploaded by

    Angelica Cassandra Villena
    This document is a drug study for a 42-year-old male patient named JB who was admitted on August 6, 2014 for post cholelithiasis and prescribed the drug Mefenamic Acid. Mefenamic Acid is a nonsteroidal anti-inflammatory drug (NSAID) to be taken three times daily for pain, fever, and inflammation. Potential side effects include gastrointestinal issues, headaches, and renal problems. Nursing responsibilities include administering the medication correctly and monitoring the patient for effectiveness, side effects, and lab abnormalities.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 3
    At a glance
    Powered by AI
    The document discusses the drug mefenamic acid, including its uses, side effects, and nursing responsibilities.

    The drug being discussed is mefenamic acid, which is a nonsteroidal anti-inflammatory drug (NSAID).

    Some potential side effects of mefenamic acid include GI disturbances, peptic ulceration, GI bleeding, headache, drowsiness, dizziness, and renal failure.

    Republic of the Philippines

    CAVITE STATE UNIVERSITY


    (CvSU)
    Don Severino Delas Alas Campus
    Indang, Cavite
    (046) 4150-010 / 4150-011 (046) 4150-012

    DRUG STUDY
    NAME OF PATIENT: JB DATE OF ADMISSION: AUGUST 6, 2014
    AGE: 42 YEARS OLD DIAGNOSIS: POST CHOLELITHIASIS
    SEX: MALE
    Drug Features
    Mechanism of
    Action
    Indication

    Contraindication

    Effects Nursing Responsibilities
    Generic Name:
    MEFENAMIC ACID
    Brand Name:

    Classification:
    NONSTEROIDAL
    ANTI-
    INFLAMMATORY
    AGENTS
    Sub Classification:
    NONE
    Dosage:
    500 mg
    Route:
    PO once in diet
    Frequency:
    TID
    Form:
    Capsule
    Color:
    Blue green and
    cream white
    capsule color
    Analgesics and
    anti-inflammatory
    effects: inhibition
    of prostaglandin
    synthesis.
    Antipyretic
    effects:
    vasodilation and
    inhibition of
    prostaglandin
    synthesis in the
    CNS.
    COX-2 inhibitors
    may cause less GI
    bleeding.
    Control mild to
    moderate pain, fever,
    and various
    inflammatory
    conditions, such as
    rheumatoid arthritis
    and osteoarthritis.
    Hypersensitivity to
    aspirin is a
    contraindication.
    Use caustiously in
    patients with a
    history of bleeding
    disorders, GI
    bleeding, and severe
    hepatic, renal, or
    cardiovascular
    disease.

    Side Effects & Adverse
    Effects:
    GI disturbances, peptic
    ulceration, and GI
    bleeding, headache,
    drowsiness, dizziness,
    nervousness, visual
    disturbances, renal
    failure,
    glomerulonephritis,
    papillary necrosis
    Check for Doctors order
    Observe 10Rs of the patient in medicine
    administration

    Assessment:
    Patients who have asthma, allergies, and
    nasal polyps or who are allergic to
    tartrazine are at an increased risk for
    developing hypersensitivity
    reactions.
    Pain: Assess pain and limitation of
    movement; note type, location, and
    intensity before and at the peak (see
    Time/Action Profile) after
    administration.
    Fever: Assess fever and note associated
    signs (diaphoresis, tachycardia,
    malaise, chills).
    Lab Test Considerations: Monitor hepatic
    function before antirheumatic
    therapy and if symptoms of
    hepatotoxicity occur; more likely in
    patients, especially children, with
    rheumatic fever, systemic lupus
    erythematosus, juvenile arthritis, or
    pre-existing hepatic disease. May
    cause serum AST, ALT, and
    alkaline phosphatase, especially


    when plasma concentrations exceed
    25 mg/100 mL. May return to
    normal despite continued use or
    dose reduction. If severe
    abnormalities or active liver disease
    occurs, discontinue and use with
    caution in future.
    May alter results of serum uric acid,
    urine vanillylmandelic acid (VMA),
    protirelin-induced thyroid-
    stimulating hormone (TSH), urine
    hydroxyindoleacetic acid (5-HIAA)
    determinations, and radionuclide
    thyroid imaging.
    Prolongs bleeding time for 47 days and,
    in large doses, may cause prolonged
    prothrombin time. Monitor
    hematocrit periodically in prolonged
    high-dose therapy to assess for GI
    blood loss .
    Toxicity and Overdose: Monitor for the
    onset of tinnitus, headache,
    hyperventilation, agitation, mental
    confusion, lethargy, diarrhea, and
    sweating. If these symptoms appear,
    withhold medication and notify physician
    or other health care professional
    immediately.
    Patient/Family Teaching
    Instruct patient to take with a full glass
    of water and to remain in an upright
    position for 1530 min after
    administration.
    Advise patient to report tinnitus; unusual
    bleeding of gums; bruising; black, tarry
    stools; or fever lasting longer than 3
    days.


    Caution patient to avoid concurrent use
    of alcohol with this medication to
    minimize possible gastric irritation; 3 or
    more glasses of alcohol per day may
    increase the risk of GI bleeding. Caution
    patient to avoid taking concurrently with
    acetaminophen or NSAIDs for more than
    a few days, unless directed by health
    care professional to prevent analgesic
    nephropathy.
    Tablets with an acetic (vinegar-like) odor
    should be discarded.
    Advise patients on long-term therapy to
    inform health care professional of
    medication regimen before surgery.

    You might also like